Current Product Range
At Little Green Pharma we are focused on manufacturing a range of medical cannabis preparations with differing cannabinoid profiles and optimal delivery methods.
Our current products are manufactured locally in Australia using a whole-plant extract formulation and with a variety of THC and CBD ratios to suit a number of conditions commonly treated with medicinal cannabis. They are presented in a simple oil formulation, providing practitioners with a high-quality, reliable product for patients.
Little Green Pharma is also championing a product development pipeline that includes:
A natural version of each product range which seeks to preserve the original carboxylated profile of the cannabis flower, thus retaining high levels of cannabioids CBDA and non-intoxicating THCA. Learn more about the potential benefits of THC/CBD or additional cannabinoids.
An advanced formulation using enhanced delivery systems. These novel patented formulations are anticipated to deliver micro-doses more readily absorbed into the body.
The key benefits of our proposed future LGP Advanced products are expected to include:
- High bio-availability: Little Green Pharma’s advanced formulations are expected to achieve therapeutic effectiveness with lower dosage, meaning less active ingredient is needed; and
- Cost saving and higher margins: Lower dose active ingredient quantities are anticipated to result in lower-cost production
Want to know more?
Please contact us to learn when our LGP Natural and Advanced ranges will be available.